ArticlePloS one2026
ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary glomerulonephritis (pGN) is a significant contributor to end-stage kidney disease (ESKD) and presents a significant healthcare burden. However, the epidemiology of ESKD-pGN in the UK remains poorly characterised.
methodsWe analysed UK Renal Registry data for adults initiating kidney replacement therapy (KRT) between 1999 and 2019, with follow-up to December 2021. The incident cohort included patients starting KRT from 2008 onwards, when national population coverage was achieved, reflecting incidence of KRT initiation due to primary glomerulonephritis rather than overall disease incidence. Incidence rates were normalised to population and analysed using multivariable Poisson regression. Overall patient and graft survival were assessed using Cox regression models with time-dependent covariates, adjusted for demographic variables. Patients managed conservatively were not captured, limiting conclusions to advanced disease requiring KRT. Adult polycystic kidney disease (ADPKD) served as a reference disease.
resultsThe cohort included 10,308 pGN and 8,302 ADPKD patients. Median age at KRT start in pGN was 54 years, with 71.6% male. Overall incidence of KRT from pGN was 11.8 pmp, with rates of 17.4 pmp for males and 6.6 pmp for females, mainly driven by IgAN, rising until 2015 then declining. ADPKD incidence was 9.8 (males) and 8.2 (females) pmp. Incidence varied by age, sex, and deprivation, with higher rates in older adults with MN (IRR 1.75, 95% CI 1.45-2.11) and MPGN (IRR 1.70, 95% CI 1.22-2.38) compared with ADPKD. Pre-emptive transplantation was less common in pGN (13.5%) than ADPKD (22.8%). Overall survival was similar, but outcomes differed by modality: in pGN, 10-year survival was 81.8% after transplantation, 55.5% on PD, and 37.9% on haemodialysis. Among pGN subtypes, IgAN had favourable graft survival and comparable 5-year survival on PD and transplantation (92.1% vs 92.6%). Graft survival was highest in ADPKD.
conclusionsThis national study reveals evolving epidemiology from ESKD-pGN in the UK. These findings may inform resource allocation, and targeted interventions to enhance care and outcomes in pGN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.